<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01224899</url>
  </required_header>
  <id_info>
    <org_study_id>SymBlock Trial</org_study_id>
    <nct_id>NCT01224899</nct_id>
  </id_info>
  <brief_title>Surgical Sympathetic Blockade in Heart Failure</brief_title>
  <acronym>SymBlock</acronym>
  <official_title>Left Cervico-Thoracic Sympathetic Blockade by Clipping in Systolic Heart Failure: A Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators sought to evaluate the feasibility and safety of surgical sympathetic
      blockade in systolic heart failure patients and secondary to assess its cardiovascular
      consequences.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">July 2010</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Perioperative mortality and morbidity</measure>
    <time_frame>30 days after operation</time_frame>
    <description>Study interruption criteria:
death attributable to surgical procedure;
cardiogenic shock attributable to surgical procedure;
worsening of heart failure symptoms attributable to surgical procedure;
Horner's syndrome
hypotension or bradiarrhythmia attributable to surgical procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular effects</measure>
    <time_frame>6 months</time_frame>
    <description>left ventricle ejection fraction (echo and gated blood pool)
end left ventricle diastolic diameter
mean heart rate
heart rate variability
New York Heart Association functional class
Minesotta Living with Heart Failure Questionnaire Score
peak oxygen consumption
walked distance in 6 minute walking test
BNP
123-I-Metaiodobenzylguanidine (late heart/mediastinum ratio)
sympathetic peripheral nerve activity (microneurography)
baroreflex parameters (low and high frequency)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Systolic Heart Failure</condition>
  <condition>Beta-blockers Intolerance</condition>
  <condition>Beta-blockers Resistance</condition>
  <arm_group>
    <arm_group_label>Surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Left cervico-thoracic sympathetic blockade</intervention_name>
    <description>Left cervico-thoracic sympathetic blockade by videothoracoscopic clipping under general anesthesia and single-lumen orotracheal intubation in semi-sitting position.</description>
    <arm_group_label>Surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  chronic heart failure (at least 1 month of symptoms onset)

          -  NYHA functional class II or III

          -  LV ejection fraction 40% or lower

          -  resting heart rate higher than 65 bpm

          -  either maximum beta-blocker therapy according to guidelines or no beta-blocker use for
             intolerance.

        Exclusion Criteria:

          -  NYHA functional class I or IV

          -  cardiogenic shock

          -  resting heart rate ≤ 65 bpm

          -  systolic blood pressure &lt; 90 mmHg

          -  sustained ventricular tachycardia

          -  eligibility to other surgical procedures

          -  procedure-limiting comorbidity

          -  presence of ICD or pacemaker

          -  valvar, chagasic or congenital cardiomyopathy

          -  age &gt; 70 years

          -  patient refusal

          -  contra-indication to videothoracoscopy

          -  decompensated thyroid disease

          -  atrial fibrillation or flutter

          -  active infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edimar A Bocchi, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Heart Institute (InCor) HC FMUSP</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paulo M Pego-Fernandes, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heart Institute (InCor) HC FMUSP</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heart Institute (InCor) do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <zip>05403000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 2010</study_first_submitted>
  <study_first_submitted_qc>October 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2010</study_first_posted>
  <last_update_submitted>October 19, 2010</last_update_submitted>
  <last_update_submitted_qc>October 19, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 20, 2010</last_update_posted>
  <responsible_party>
    <name_title>Paulo Manuel Pego Fernandes</name_title>
    <organization>Heart Institute (InCor) HC FMUSP</organization>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>Sympathetic Nervous System</keyword>
  <keyword>Sympathectomy</keyword>
  <keyword>Adrenergic beta-Antagonists</keyword>
  <keyword>Ventricular Dysfunction, Left</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Failure, Systolic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

